AU2021900345A0 - Agents and methods for therapy and prophylaxis - Google Patents

Agents and methods for therapy and prophylaxis

Info

Publication number
AU2021900345A0
AU2021900345A0 AU2021900345A AU2021900345A AU2021900345A0 AU 2021900345 A0 AU2021900345 A0 AU 2021900345A0 AU 2021900345 A AU2021900345 A AU 2021900345A AU 2021900345 A AU2021900345 A AU 2021900345A AU 2021900345 A0 AU2021900345 A0 AU 2021900345A0
Authority
AU
Australia
Prior art keywords
prophylaxis
therapy
agents
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021900345A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ViraLok Therapeutics Pty Ltd
Original Assignee
ViraLok Therapeutics Pty Ltd
Filing date
Publication date
Application filed by ViraLok Therapeutics Pty Ltd filed Critical ViraLok Therapeutics Pty Ltd
Publication of AU2021900345A0 publication Critical patent/AU2021900345A0/en
Priority to PCT/AU2022/050089 priority Critical patent/WO2022170396A1/en
Pending legal-status Critical Current

Links

AU2021900345A 2021-02-12 2021-02-12 Agents and methods for therapy and prophylaxis Pending AU2021900345A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2022/050089 WO2022170396A1 (en) 2021-02-12 2022-02-11 Agents and methods for therapy and prophylaxis

Publications (1)

Publication Number Publication Date
AU2021900345A0 true AU2021900345A0 (en) 2021-02-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3920923A4 (en) Therapeutic agents and methods of treatment
EP3934615A4 (en) Compositions and methods for treating acne
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP4096675A4 (en) Compositions and methods for treating long covid
EP4048396A4 (en) Methods and apparatus for phototherapy
EP3938514A4 (en) Compounds and methods for reducing kcnt1 expression
EP4117655A4 (en) Treatment methods
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3965799A4 (en) Compositions and synergistic methods for treating infections
AU2021903239A0 (en) Agents and methods for therapy and prophylaxis
AU2021900345A0 (en) Agents and methods for therapy and prophylaxis
GB202217355D0 (en) Methods for the prophylaxis and treatment of Covid and Covid-19
EP3999065A4 (en) Therapeutic compositions and methods for treating cancers
EP3999092A4 (en) Combination cancer therapy agents and methods
EP3999076A4 (en) Compositions and methods for treating skin conditions
EP3996752A4 (en) Compositions and methods for treating peroxisomal biogenesis disorders
EP4013401A4 (en) Articles and methods for administration of therapeutic agents
EP3955943A4 (en) Gmci and ddri combination therapy for treating cancer
AU2020901854A0 (en) Therapeutic methods and agents
AU2020901800A0 (en) Therapeutic methods and agents
AU2020901796A0 (en) Compositions and methods for treatment
AU2021901067A0 (en) Therapeutic agents and uses therefor
AU2020901994A0 (en) Therapeutic agents and uses therefor
AU2021903484A0 (en) Methods and compositions for treating skin
AU2020903941A0 (en) Methods and compositions for treating skin